GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 46 filers reported holding GALERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,802,927 | +21.9% | 898,374 | 0.0% | 0.11% | +25.0% |
| Q1 2023 | $2,299,837 | +71.8% | 898,374 | 0.0% | 0.09% | +72.5% |
| Q4 2022 | $1,338,577 | -14.4% | 898,374 | 0.0% | 0.05% | -20.3% |
| Q3 2022 | $1,563,000 | +33.8% | 898,374 | 0.0% | 0.06% | +39.1% |
| Q2 2022 | $1,168,000 | -45.4% | 898,374 | 0.0% | 0.05% | -38.7% |
| Q1 2022 | $2,138,000 | -48.2% | 898,374 | 0.0% | 0.08% | -43.6% |
| Q4 2021 | $4,124,000 | -43.3% | 898,374 | 0.0% | 0.13% | -43.2% |
| Q3 2021 | $7,277,000 | -28.9% | 898,374 | -13.8% | 0.23% | -29.7% |
| Q2 2021 | $10,241,000 | +11.4% | 1,041,845 | 0.0% | 0.33% | +5.4% |
| Q1 2021 | $9,189,000 | -13.8% | 1,041,845 | 0.0% | 0.32% | -15.7% |
| Q4 2020 | $10,658,000 | +13.2% | 1,041,845 | 0.0% | 0.38% | +6.2% |
| Q3 2020 | $9,418,000 | +26.6% | 1,041,845 | 0.0% | 0.35% | +24.7% |
| Q2 2020 | $7,439,000 | +87.9% | 1,041,845 | +150.0% | 0.28% | +58.1% |
| Q1 2020 | $3,958,000 | -27.8% | 416,666 | 0.0% | 0.18% | -13.5% |
| Q4 2019 | $5,483,000 | – | 416,666 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $107,375 | 0.09% |
| Sofinnova Investments, Inc. | 3,083,712 | $539,958 | 0.03% |
| MANCHESTER FINANCIAL INC | 49,900 | $8,738 | 0.00% |
| Good Life Advisors, LLC | 31,250 | $5,472 | 0.00% |
| Blackstone Inc. | 1,678,984 | $293,822 | 0.00% |
| Pinnacle Wealth Management Advisory Group, LLC | 47,695 | $8,351 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 302,506 | $52,939 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,974 | $2,097 | 0.00% |
| MORGAN STANLEY | 2,834 | $497 | 0.00% |
| Invesco Ltd. | 157,653 | $27,605 | 0.00% |